Natural Health Product Research Society (NHPRS) of Canada hosts 14th annual conference, Beyond Tradition

Natural Health Product Research Society (NHPRS) of Canada hosts 14th annual conference, Beyond Tradition

Published on April 25, 2017

The Natural Health Product Research Society (NHPRS) of Canada is pleased to host its 14th annual conference, Beyond Tradition, May 8-11, 2017, at the Pinnacle Hotel Waterfront in Vancouver, British Columbia.  With over 250 expected participants, this 4-day event will provide a great opportunity to learn from leaders in the Natural Health Product (NHP) sector, as they discuss key regulatory and quality assurance updates, as well as next innovations in NHP research.  Join the NHPRS as they host speakers from Health Canada, UNPA, USP, AHP, USDA, Chinese Pharmacopoeia, Academia, and key members of the North American health products industry, presenting on current topics in key NHP fields. 

This years’ event will feature focused sessions on Botanical Authentication; Regulatory and Government Affairs; Personalized Nutrition; Industrial Innovations and Emerging Technologies; Ethnobotany, Pharmacology & Traditional Medicine; Modernization of Pharmacopoeial Standards; Gut Health and the Intestinal Microbiome; and Cannabis.  Enjoy a pre-conference workshop, “Frontiers in NHP Research”; participate in the One-to-One Partnering program, and enjoy great social events in Vancouver, including a local Brewery/Distillery Tour and Conference Gala dinner.

Visit the NHPRS website to learn more about this exciting upcoming Canadian NHP industry event! 

Related Articles

Health Canada’s Proposal for Clinical Trials Regulatory Modernization

Health Canada’s Proposal for Clinical Trials Regulatory Modernization

On May 20, 2021 Health Canada opened a consultation on its proposal to modernize the regulatory framework for clinical trials related to human drugs, medical devices,...

Interim Order No. 2 Respecting Clinical Trials for Medical Devices and Drugs Relating to COVID-19

Interim Order No. 2 Respecting Clinical Trials for Medical Devices and Drugs Relating to COVID-19

In response to the ongoing need for innovative COVID-19 diagnosis, treatment, mitigation, or prevention options, Health Canada announced the approval of Interim Order No. 2...